Meridian Medical Technologies, a unit of CDMO Kindeva, snared a $129 million contract to supply the United States with the chemical nerve agent antidote autoinjector DuoDote. The FDA-approved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback